Pleiotropic effects under combined therapy with empagliflozin and linagliptin compared to metformin and insulin glargine in patients with type 2 diabetes

Jung S, Ott C, Kannenkeril D, Bosch A, Karg M, Striepe K, Bramlage P, Schmieder R (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Diabetologia Springer Verlag (Germany)

Publisher: SPRINGER

City/Town: NEW YORK

Pages Range: S357-S358

Conference Proceedings Title: DIABETOLOGIA

Event location: Barcelona ES

Authors with CRIS profile

Susan Jung Department of Paediatrics and Adolescent Medicine Christian Ott Medizinische Fakultät Agnes Bosch Department of Medicine 4 – Nephrology and Hypertension Kristina Striepe Professur für Innere Medizin (Nephrologie) Roland Schmieder Professur für Innere Medizin (Nephrologie)

Involved external institutions

Institut für Pharmakologie und präventive Medizin (IPPMed GmbH) DE Germany (DE)

How to cite

APA:

Jung, S., Ott, C., Kannenkeril, D., Bosch, A., Karg, M., Striepe, K.,... Schmieder, R. (2019). Pleiotropic effects under combined therapy with empagliflozin and linagliptin compared to metformin and insulin glargine in patients with type 2 diabetes. In DIABETOLOGIA (pp. S357-S358). Barcelona, ES: NEW YORK: SPRINGER.

MLA:

Jung, Susan, et al. "Pleiotropic effects under combined therapy with empagliflozin and linagliptin compared to metformin and insulin glargine in patients with type 2 diabetes." Proceedings of the 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Barcelona NEW YORK: SPRINGER, 2019. S357-S358.

BibTeX: Download